2020. A Prospective, Multicenter, Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination Of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s90. DOI:https://doi.org/10.25251/skin.4.supp.90.